CRISPR/Cas
EPO revokes first Sigma-Aldrich CRISPR patent for lack of inventive step
The EPO Opposition Division has revoked a CRISPR patent, part of the Sigma-Aldrich patent portfolio, for lack of inventive step. The revocation is sig
...
19 March 2021 by Amy Sandys
